Isracann Biosciences Inc.
ISCNF
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 82.44% | 81.62% | -39.96% | -23.94% | -19.00% |
| Total Depreciation and Amortization | -0.91% | 3.44% | 13.82% | 8.28% | 1.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.66% | -89.76% | 81.87% | 95.02% | 80.42% |
| Change in Net Operating Assets | 177.90% | 1,569.52% | -68.04% | -81.51% | -4.68% |
| Cash from Operations | 60.76% | 57.47% | 38.24% | 51.50% | 59.63% |
| Capital Expenditure | -- | -- | -540.00% | -10,900.00% | -10,900.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -81.43% | -81.43% | -- |
| Other Investing Activities | 100.00% | 15.68% | 89.27% | 89.27% | 89.27% |
| Cash from Investing | 1,007.14% | -164.94% | 85.55% | 85.58% | 100.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.63% | -94.03% | -44.62% | -15.23% | -84.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 20.41% |
| Cash from Financing | -85.24% | -94.03% | -38.90% | 10.48% | -84.92% |
| Foreign Exchange rate Adjustments | -1,815.79% | -1,870.59% | -87.47% | -97.93% | 81.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.70% | 5.55% | 54.35% | 79.85% | -330.34% |